Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

NCT06637163 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Benmelstobart+ Paclitaxel + Carboplatin+ Radiotherapy
DRUG: Paclitaxel + Carboplatin + Radiotherapy

Sponsor

Shanghai Zhongshan Hospital